About this episode
We continue our myeloma series, transitioning our discussion from autologous stem cell transplant to maintenance therapy for myeloma. Content: - Why do we use revlimid (lenalidomide) maintenance? - What about in high risk patients? - What is the role of MRD testing? - What about daratumumab in the maintenance setting? This episode has been sponsored by Primum. To sign up for a free account, check out: tfoc.primum.co. Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes Love what you hear? Tell a friend and leave a review on our podcast streaming platforms! Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast